| Patient | Ada Lovelace |
|---|---|
| Date of birth | 1815-12-10 |
| Identifiers | MRN HR-NI031-SYN-TD; SSN (made up) 000-31-6729 |
| Document date | 1851-06-02 |
| Author | Constance Whitley-Adeyemi, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Friable exophytic cervical mass with five months of abnormal bleeding and constant pelvic pain in a 35-year-old woman, biopsied today, with iron deficiency anemia. Please confirm the diagnosis, stage the disease, advise on treatment intent and options, and help with control of bleeding and pain. [S]
Urgency: Within two weeks; pathology expected within a week. [S]
Questions for the consultant:
Mathematician, 35, with five months of bleeding between periods and after intercourse, heavier periods, a watery blood-stained discharge, and a constant pelvic ache, average 7 of 10. She has taken prescribed opium tincture, 0.5 mL four to six times a day and measured at times with a household spoon, for about two years for recurrent pelvic and abdominal pain; today it was changed to measured oral morphine solution 5 mg every 4 hours as needed, with acetaminophen, laxatives and naloxone. No opioid use disorder on assessment. Earlier history of measles in childhood, cholera in her early twenties, and chronic ill health with asthma and digestive problems. Never smoked. On speculum examination a 5 cm friable exophytic mass replaces the cervix and bleeds on contact; on bimanual and rectovaginal examination the left parametrium feels thickened, not reaching the sidewall. Punch biopsy and HPV typing sent. Hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, platelets 412; creatinine 0.68 mg/dL; ALT 18 U/L; albumin 3.6 g/dL; serum hCG negative. First intravenous iron infusion given today. PHQ-9 8. She wants to be told everything directly and to make her own decisions, and she wants to keep her mind clear for her work [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
3 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Opium tincture (100 mg/mL opium, equivalent to 10 mg/mL morphine), 0.5 mL by mouth four to six times a day as needed for pain | 0.5 mL four to six times a day as needed | Oral route | 1849-06-03 to 1851-06-02 | completed | S |
| Morphine sulfate oral solution 2 mg/mL, 5 mg (2.5 mL by oral syringe) every 4 hours as needed for pain | 5 mg every 4 hours as needed | Oral route | 1851-06-02 | active | S |
| Naloxone 4 mg nasal spray, one spray in a nostril for suspected opioid overdose; call 911 | one spray as needed for suspected overdose; repeat after 2 to 3 minutes if needed | Nasal route | 1851-06-02 | active | S |
| Senna 8.6 mg tablet, two tablets by mouth at night | two tablets at night | Oral route | 1851-06-02 | active | S |
| Polyethylene glycol 3350, 17 g in water by mouth once or twice a day | once daily, up to twice daily | Oral route | 1851-06-02 | active | S |
| Acetaminophen 500 mg tablet, two tablets by mouth three times a day | 1 g three times a day | Oral route | 1851-06-02 | active | S |
| Ferric carboxymaltose 750 mg intravenous infusion, two doses at the first two visits | 750 mg on two occasions two weeks apart | Intravenous route | 1851-06-02 to 1851-06-17 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bleeding between periods and after intercourse, with heavier periods, a watery blood-stained discharge and a constant pelvic ache, for about five months; average pain 7 of 10 despite her opium tincture; a friable cervical mass found on examination and biopsied; cause not yet established at intake | active | confirmed | N93.8 | S — Synthetic presenting problem anchored to her documented final illness; superseded by the diagnosis at the second visit. |
| Iron deficiency anemia from chronic blood loss: hemoglobin 8.4 g/dL, mean cell volume 74 fL, ferritin 5 ng/mL, with tiredness and breathlessness on stairs | active | confirmed | D50.0 | S — Synthetic modern finding anchored to her documented final illness. |
| Long-term prescribed opioid therapy: opium tincture for recurrent pelvic and abdominal pain for about two years, measured at times with a household spoon, converted at intake to measured oral morphine; no opioid use disorder on a DSM-5 assessment; naloxone supplied | active | confirmed | Z79.891 | S — Synthetic modern history anchored to her documented laudanum and opium; not a claim about her real dosing. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1829 | Measles at 13, with a long recovery and about a year in bed | D (CLM-0002) |
| 1837 | Cholera at 21, followed by lingering asthma and digestive problems | D (CLM-0004) |
| from about 1843 | Chronic ill health from her late twenties, with episodes she called heart or rheumatic attacks, treated with several medicines including laudanum and opium | D (CLM-0005, CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | A poet; died at 36; cause not recorded in the cited source | D (CLM-0001) |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1851-06-02 | Body height | 165 | cm | S |
| 1851-06-02 | Body weight | 54 | kg | S |
| 1851-06-02 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 1851-06-02 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1851-06-02 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1851-06-02 | Heart rate | 96 | /min | S |
| 1851-06-02 | Respiratory rate | 16 | /min | S |
| 1851-06-02 | Body temperature | 36.8 | Cel | S |
| 1851-06-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1851-06-02 | Hemoglobin [Mass/volume] in Blood | 8.4 | g/dL | 12-15.5 g/dL | Low | S |
| 1851-06-02 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 74 | fL | 80-100 fL | Low | S |
| 1851-06-02 | Leukocytes [#/volume] in Blood by Automated count | 7.8 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1851-06-02 | Platelets [#/volume] in Blood by Automated count | 412 | 10*3/uL | 150-400 10*3/uL | High | S |
| 1851-06-02 | Ferritin [Mass/volume] in Serum or Plasma | 5 | ng/mL | 15-150 ng/mL | Low | S |
| 1851-06-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.68 | mg/dL | 0.57-1 mg/dL | Normal | S |
| 1851-06-02 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 1851-06-02 | Albumin [Mass/volume] in Serum or Plasma | 3.6 | g/dL | 3.5-5 g/dL | Normal | S |
| 1851-06-02 | Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma | 1 | m[IU]/mL | Below 5 is negative | Normal | S |
| 1851-06-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1846)/1.73 sq M | 116 | mL/min/{1.73_m2} | 60 or more | Normal | S |
| 1851-06-02 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 7 | {score} | S | ||
| 1851-06-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S |